Global Efavirenz Market Growth 2025-2031

December 2025 | 86 pages | ID: GCBE9B6855CEN
LP Information

Abstracts

The global Efavirenz market size is predicted to grow from US$ 140 million in 2025 to US$ 184 million in 2031; it is expected to grow at a CAGR of 4.7% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Efavirenz (EFV), sold under the brand names Sustiva among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the “Efavirenz Industry Forecast” looks at past sales and reviews total world Efavirenz sales in 2024, providing a comprehensive analysis by region and market sector of projected Efavirenz sales for 2025 through 2031. With Efavirenz sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Efavirenz industry.

This Insight Report provides a comprehensive analysis of the global Efavirenz landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Efavirenz portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Efavirenz market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Efavirenz and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Efavirenz.

This report presents a comprehensive overview, market shares, and growth opportunities of Efavirenz market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Two-drug combination
• Three-drug combination

Segmentation by Application:

• Adults
• Children

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Bristol-Myers Squibb
• Teva
• Mylan
• Aurobindo Pharma
• Cipla
• Macleods Pharmaceuticals
• Hetero

Key Questions Addressed in this Report

What is the 10-year outlook for the global Efavirenz market?

What factors are driving Efavirenz market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Efavirenz market opportunities vary by end market size?

How does Efavirenz break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Efavirenz Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Efavirenz by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Efavirenz by Country/Region, 2020, 2024 & 2031
2.2 Efavirenz Segment by Type
  2.2.1 Two-drug combination
  2.2.2 Three-drug combination
2.3 Efavirenz Sales by Type
  2.3.1 Global Efavirenz Sales Market Share by Type (2020-2025)
  2.3.2 Global Efavirenz Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Efavirenz Sale Price by Type (2020-2025)
2.4 Efavirenz Segment by Application
  2.4.1 Adults
  2.4.2 Children
2.5 Efavirenz Sales by Application
  2.5.1 Global Efavirenz Sale Market Share by Application (2020-2025)
  2.5.2 Global Efavirenz Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Efavirenz Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Efavirenz Breakdown Data by Company
  3.1.1 Global Efavirenz Annual Sales by Company (2020-2025)
  3.1.2 Global Efavirenz Sales Market Share by Company (2020-2025)
3.2 Global Efavirenz Annual Revenue by Company (2020-2025)
  3.2.1 Global Efavirenz Revenue by Company (2020-2025)
  3.2.2 Global Efavirenz Revenue Market Share by Company (2020-2025)
3.3 Global Efavirenz Sale Price by Company
3.4 Key Manufacturers Efavirenz Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Efavirenz Product Location Distribution
  3.4.2 Players Efavirenz Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR EFAVIRENZ BY GEOGRAPHIC REGION

4.1 World Historic Efavirenz Market Size by Geographic Region (2020-2025)
  4.1.1 Global Efavirenz Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Efavirenz Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Efavirenz Market Size by Country/Region (2020-2025)
  4.2.1 Global Efavirenz Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Efavirenz Annual Revenue by Country/Region (2020-2025)
4.3 Americas Efavirenz Sales Growth
4.4 APAC Efavirenz Sales Growth
4.5 Europe Efavirenz Sales Growth
4.6 Middle East & Africa Efavirenz Sales Growth

5 AMERICAS

5.1 Americas Efavirenz Sales by Country
  5.1.1 Americas Efavirenz Sales by Country (2020-2025)
  5.1.2 Americas Efavirenz Revenue by Country (2020-2025)
5.2 Americas Efavirenz Sales by Type (2020-2025)
5.3 Americas Efavirenz Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Efavirenz Sales by Region
  6.1.1 APAC Efavirenz Sales by Region (2020-2025)
  6.1.2 APAC Efavirenz Revenue by Region (2020-2025)
6.2 APAC Efavirenz Sales by Type (2020-2025)
6.3 APAC Efavirenz Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Efavirenz by Country
  7.1.1 Europe Efavirenz Sales by Country (2020-2025)
  7.1.2 Europe Efavirenz Revenue by Country (2020-2025)
7.2 Europe Efavirenz Sales by Type (2020-2025)
7.3 Europe Efavirenz Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Efavirenz by Country
  8.1.1 Middle East & Africa Efavirenz Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Efavirenz Revenue by Country (2020-2025)
8.2 Middle East & Africa Efavirenz Sales by Type (2020-2025)
8.3 Middle East & Africa Efavirenz Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Efavirenz
10.3 Manufacturing Process Analysis of Efavirenz
10.4 Industry Chain Structure of Efavirenz

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Efavirenz Distributors
11.3 Efavirenz Customer

12 WORLD FORECAST REVIEW FOR EFAVIRENZ BY GEOGRAPHIC REGION

12.1 Global Efavirenz Market Size Forecast by Region
  12.1.1 Global Efavirenz Forecast by Region (2026-2031)
  12.1.2 Global Efavirenz Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Efavirenz Forecast by Type (2026-2031)
12.7 Global Efavirenz Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Bristol-Myers Squibb
  13.1.1 Bristol-Myers Squibb Company Information
  13.1.2 Bristol-Myers Squibb Efavirenz Product Portfolios and Specifications
  13.1.3 Bristol-Myers Squibb Efavirenz Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Bristol-Myers Squibb Main Business Overview
  13.1.5 Bristol-Myers Squibb Latest Developments
13.2 Teva
  13.2.1 Teva Company Information
  13.2.2 Teva Efavirenz Product Portfolios and Specifications
  13.2.3 Teva Efavirenz Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Teva Main Business Overview
  13.2.5 Teva Latest Developments
13.3 Mylan
  13.3.1 Mylan Company Information
  13.3.2 Mylan Efavirenz Product Portfolios and Specifications
  13.3.3 Mylan Efavirenz Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Mylan Main Business Overview
  13.3.5 Mylan Latest Developments
13.4 Aurobindo Pharma
  13.4.1 Aurobindo Pharma Company Information
  13.4.2 Aurobindo Pharma Efavirenz Product Portfolios and Specifications
  13.4.3 Aurobindo Pharma Efavirenz Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Aurobindo Pharma Main Business Overview
  13.4.5 Aurobindo Pharma Latest Developments
13.5 Cipla
  13.5.1 Cipla Company Information
  13.5.2 Cipla Efavirenz Product Portfolios and Specifications
  13.5.3 Cipla Efavirenz Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Cipla Main Business Overview
  13.5.5 Cipla Latest Developments
13.6 Macleods Pharmaceuticals
  13.6.1 Macleods Pharmaceuticals Company Information
  13.6.2 Macleods Pharmaceuticals Efavirenz Product Portfolios and Specifications
  13.6.3 Macleods Pharmaceuticals Efavirenz Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Macleods Pharmaceuticals Main Business Overview
  13.6.5 Macleods Pharmaceuticals Latest Developments
13.7 Hetero
  13.7.1 Hetero Company Information
  13.7.2 Hetero Efavirenz Product Portfolios and Specifications
  13.7.3 Hetero Efavirenz Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Hetero Main Business Overview
  13.7.5 Hetero Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Efavirenz Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Efavirenz Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Two-drug combination
Table 4. Major Players of Three-drug combination
Table 5. Global Efavirenz Sales by Type (2020-2025) & (K Units)
Table 6. Global Efavirenz Sales Market Share by Type (2020-2025)
Table 7. Global Efavirenz Revenue by Type (2020-2025) & ($ million)
Table 8. Global Efavirenz Revenue Market Share by Type (2020-2025)
Table 9. Global Efavirenz Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Efavirenz Sale by Application (2020-2025) & (K Units)
Table 11. Global Efavirenz Sale Market Share by Application (2020-2025)
Table 12. Global Efavirenz Revenue by Application (2020-2025) & ($ million)
Table 13. Global Efavirenz Revenue Market Share by Application (2020-2025)
Table 14. Global Efavirenz Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Efavirenz Sales by Company (2020-2025) & (K Units)
Table 16. Global Efavirenz Sales Market Share by Company (2020-2025)
Table 17. Global Efavirenz Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Efavirenz Revenue Market Share by Company (2020-2025)
Table 19. Global Efavirenz Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Efavirenz Producing Area Distribution and Sales Area
Table 21. Players Efavirenz Products Offered
Table 22. Efavirenz Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Efavirenz Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Efavirenz Sales Market Share Geographic Region (2020-2025)
Table 27. Global Efavirenz Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Efavirenz Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Efavirenz Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Efavirenz Sales Market Share by Country/Region (2020-2025)
Table 31. Global Efavirenz Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Efavirenz Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Efavirenz Sales by Country (2020-2025) & (K Units)
Table 34. Americas Efavirenz Sales Market Share by Country (2020-2025)
Table 35. Americas Efavirenz Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Efavirenz Sales by Type (2020-2025) & (K Units)
Table 37. Americas Efavirenz Sales by Application (2020-2025) & (K Units)
Table 38. APAC Efavirenz Sales by Region (2020-2025) & (K Units)
Table 39. APAC Efavirenz Sales Market Share by Region (2020-2025)
Table 40. APAC Efavirenz Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Efavirenz Sales by Type (2020-2025) & (K Units)
Table 42. APAC Efavirenz Sales by Application (2020-2025) & (K Units)
Table 43. Europe Efavirenz Sales by Country (2020-2025) & (K Units)
Table 44. Europe Efavirenz Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Efavirenz Sales by Type (2020-2025) & (K Units)
Table 46. Europe Efavirenz Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Efavirenz Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Efavirenz Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Efavirenz Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Efavirenz Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Efavirenz
Table 52. Key Market Challenges & Risks of Efavirenz
Table 53. Key Industry Trends of Efavirenz
Table 54. Efavirenz Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Efavirenz Distributors List
Table 57. Efavirenz Customer List
Table 58. Global Efavirenz Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Efavirenz Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Efavirenz Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Efavirenz Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Efavirenz Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Efavirenz Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Efavirenz Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Efavirenz Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Efavirenz Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Efavirenz Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Efavirenz Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Efavirenz Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Efavirenz Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Efavirenz Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Bristol-Myers Squibb Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 73. Bristol-Myers Squibb Efavirenz Product Portfolios and Specifications
Table 74. Bristol-Myers Squibb Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Bristol-Myers Squibb Main Business
Table 76. Bristol-Myers Squibb Latest Developments
Table 77. Teva Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 78. Teva Efavirenz Product Portfolios and Specifications
Table 79. Teva Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Teva Main Business
Table 81. Teva Latest Developments
Table 82. Mylan Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 83. Mylan Efavirenz Product Portfolios and Specifications
Table 84. Mylan Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Mylan Main Business
Table 86. Mylan Latest Developments
Table 87. Aurobindo Pharma Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 88. Aurobindo Pharma Efavirenz Product Portfolios and Specifications
Table 89. Aurobindo Pharma Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Aurobindo Pharma Main Business
Table 91. Aurobindo Pharma Latest Developments
Table 92. Cipla Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 93. Cipla Efavirenz Product Portfolios and Specifications
Table 94. Cipla Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Cipla Main Business
Table 96. Cipla Latest Developments
Table 97. Macleods Pharmaceuticals Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 98. Macleods Pharmaceuticals Efavirenz Product Portfolios and Specifications
Table 99. Macleods Pharmaceuticals Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Macleods Pharmaceuticals Main Business
Table 101. Macleods Pharmaceuticals Latest Developments
Table 102. Hetero Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 103. Hetero Efavirenz Product Portfolios and Specifications
Table 104. Hetero Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Hetero Main Business
Table 106. Hetero Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Efavirenz
Figure 2. Efavirenz Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Efavirenz Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Efavirenz Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Efavirenz Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Efavirenz Sales Market Share by Country/Region (2024)
Figure 10. Efavirenz Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Two-drug combination
Figure 12. Product Picture of Three-drug combination
Figure 13. Global Efavirenz Sales Market Share by Type in 2025
Figure 14. Global Efavirenz Revenue Market Share by Type (2020-2025)
Figure 15. Efavirenz Consumed in Adults
Figure 16. Global Efavirenz Market: Adults (2020-2025) & (K Units)
Figure 17. Efavirenz Consumed in Children
Figure 18. Global Efavirenz Market: Children (2020-2025) & (K Units)
Figure 19. Global Efavirenz Sale Market Share by Application (2024)
Figure 20. Global Efavirenz Revenue Market Share by Application in 2025
Figure 21. Efavirenz Sales by Company in 2025 (K Units)
Figure 22. Global Efavirenz Sales Market Share by Company in 2025
Figure 23. Efavirenz Revenue by Company in 2025 ($ millions)
Figure 24. Global Efavirenz Revenue Market Share by Company in 2025
Figure 25. Global Efavirenz Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Efavirenz Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Efavirenz Sales 2020-2025 (K Units)
Figure 28. Americas Efavirenz Revenue 2020-2025 ($ millions)
Figure 29. APAC Efavirenz Sales 2020-2025 (K Units)
Figure 30. APAC Efavirenz Revenue 2020-2025 ($ millions)
Figure 31. Europe Efavirenz Sales 2020-2025 (K Units)
Figure 32. Europe Efavirenz Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Efavirenz Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa Efavirenz Revenue 2020-2025 ($ millions)
Figure 35. Americas Efavirenz Sales Market Share by Country in 2025
Figure 36. Americas Efavirenz Revenue Market Share by Country (2020-2025)
Figure 37. Americas Efavirenz Sales Market Share by Type (2020-2025)
Figure 38. Americas Efavirenz Sales Market Share by Application (2020-2025)
Figure 39. United States Efavirenz Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Efavirenz Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Efavirenz Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Efavirenz Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Efavirenz Sales Market Share by Region in 2025
Figure 44. APAC Efavirenz Revenue Market Share by Region (2020-2025)
Figure 45. APAC Efavirenz Sales Market Share by Type (2020-2025)
Figure 46. APAC Efavirenz Sales Market Share by Application (2020-2025)
Figure 47. China Efavirenz Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Efavirenz Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Efavirenz Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Efavirenz Revenue Growth 2020-2025 ($ millions)
Figure 51. India Efavirenz Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Efavirenz Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Efavirenz Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Efavirenz Sales Market Share by Country in 2025
Figure 55. Europe Efavirenz Revenue Market Share by Country (2020-2025)
Figure 56. Europe Efavirenz Sales Market Share by Type (2020-2025)
Figure 57. Europe Efavirenz Sales Market Share by Application (2020-2025)
Figure 58. Germany Efavirenz Revenue Growth 2020-2025 ($ millions)
Figure 59. France Efavirenz Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Efavirenz Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Efavirenz Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Efavirenz Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Efavirenz Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Efavirenz Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Efavirenz Sales Market Share by Application (2020-2025)
Figure 66. Egypt Efavirenz Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Efavirenz Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Efavirenz Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Efavirenz Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Efavirenz Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Efavirenz in 2025
Figure 72. Manufacturing Process Analysis of Efavirenz
Figure 73. Industry Chain Structure of Efavirenz
Figure 74. Channels of Distribution
Figure 75. Global Efavirenz Sales Market Forecast by Region (2026-2031)
Figure 76. Global Efavirenz Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Efavirenz Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Efavirenz Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Efavirenz Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Efavirenz Revenue Market Share Forecast by Application (2026-2031)